2019
DOI: 10.1038/s41598-019-55289-2
|View full text |Cite|
|
Sign up to set email alerts
|

Macrophage Mannose Receptor CD206 Predicts Prognosis in Community-acquired Pneumonia

Abstract: CD206, a mannose receptor, is mainly expressed on the surface of alternatively activated macrophages where it acts as a pattern recognition receptor and plays a role in innate and adaptive immunity. This study investigated serum soluble CD206 (sCD206) levels in community-acquired pneumonia (CAP) and examined their clinical significance. sCD206 concentrations were measured in the sera of two independent cohorts with CAP (127 and 125 patients, respectively) and 42 controls. The expression of CD206 in the lung fr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
26
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 34 publications
(30 citation statements)
references
References 34 publications
0
26
0
Order By: Relevance
“…The steady-state AMs express CD206 (a mannose receptor, which is a C-type lectin and serves as a PRR) and β-glucan specific receptor (Dectin-1), which are also expressed by alternatively-activated macrophages (AAMs) or M2 as their definitive markers (150,151). The serum CD206 (sCD206) levels increases in the patients of community-acquired pneumonia (CAP) with the increase in its severity [pneumonia severity index (PSI)], which can be used for CAP prognosis (152). Also, the infiltration of CD206 + macrophages increases in the lungs of patients with fatal pneumonia.…”
Section: Pulmonary Macrophages During Bacterial Pneumonia and Associamentioning
confidence: 99%
“…The steady-state AMs express CD206 (a mannose receptor, which is a C-type lectin and serves as a PRR) and β-glucan specific receptor (Dectin-1), which are also expressed by alternatively-activated macrophages (AAMs) or M2 as their definitive markers (150,151). The serum CD206 (sCD206) levels increases in the patients of community-acquired pneumonia (CAP) with the increase in its severity [pneumonia severity index (PSI)], which can be used for CAP prognosis (152). Also, the infiltration of CD206 + macrophages increases in the lungs of patients with fatal pneumonia.…”
Section: Pulmonary Macrophages During Bacterial Pneumonia and Associamentioning
confidence: 99%
“…Increased sMR levels were also observed in patients with a wide variety of inflammatory diseases, such as pulmonary tuberculosis ( 59 ), pulmonary fibrosis ( 60 ), multiple myeloma ( 61 , 62 ), rheumatoid arthritis ( 63 ), chronic joint inflammation ( 64 ), pneumonia ( 65 , 66 ), interstitial lung disease ( 67 , 68 ) and gastric cancer ( 69 ). Strikingly, in these studies, sMR levels positively correlated with disease severity and mortality.…”
Section: Smr Correlates With Inflammatory Diseases and Induces Macrophage Activationmentioning
confidence: 99%
“…These differences were confirmed when we compared the two groups after an infectious challenge with K. pneumoniae , as differences in the infected groups in the same markers were observed as those seen in the vehicle-treated groups. However, in response to infection, marked differences were also observed in the CMP frequency of CD206, TLR4 and Ly-6C, all of which have important host defense functions ( 27 , 28 , 33 , 34 , 51 ).…”
Section: Discussionmentioning
confidence: 99%